Question 1

What is Prelude Therapeutics Inc (PRLD) stock price today?

Accepted Answer

Prelude Therapeutics Inc (PRLD) currently trades at $5.23 per share. The stock has a market capitalization of $275.98M and a P/E ratio of —x.

Question 2

Is PRLD stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Prelude Therapeutics Inc has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Prelude Therapeutics Inc's revenue and earnings?

Accepted Answer

Prelude Therapeutics Inc has trailing twelve-month (TTM) revenue of $12.14M with profit margins of 0.00%. Earnings per share (EPS) is $-1.29.

Question 4

Is PRLD stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Prelude Therapeutics Inc's intrinsic value is $1.19, representing a margin of safety of -75.63%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$7.00M	$12.14M	$12.14M
Net income	$-107.34M	$-121.83M	$-127.17M	$-99.50M	$-16.46M
EPS	—	—	—	—	$-1.29
Free cash flow	$-86.75M	$-110.58M	$-103.65M	$-56.37M	$23.12M
Profit margin	—	—	-1,816.76%	-819.59%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PRLD	$275.98M	26	6.3	2.5	4.0	5.0	-75.63%	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Prelude Therapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare